Current calls, week 16, 2017

Published 2017-04-19 17:10. Updated 2017-04-19 17:17

Tips from KI Grants Office about current calls

Swedish and Nordic grants

Project grants - Research on alcohol, narcotics, doping, tobacco and gambling – FORTE

Use of alcohol, narcotics, doping, tobacco and gambling (ANDTG) has significant adverse effects on individuals, organisations and society at large. The consequences of over-consumption are widespread, and the pathways to addiction are complex. This call is for proposals to strengthen the research on ANDTG. Grant amount is between 0,5 and 2 million SEK per year and project for maximum three years.

Closing date: 18 May 2017

Project grants - Research on alcohol, narcotics, doping, tobacco and gambling – FORTE

Project grants - Research on ageing and health – FORTE

The proportion of older people in Sweden is increasing. This development is leading to significant challenges for both health care and aged services. Research on initiatives that support active and healthy ageing is important. This call is for proposals to strengthen the research on ageing and health. Grant amount is between 0,5 and 2 million SEK per year and project for maximum three years.

Closing date: 18 May 2017

Project grants - Research on ageing and health – FORTE

Project grants within basic and clinical research in endocrinology and metabolism – NovoNordisk

The Novo Nordisk Foundation hereby calls for applications within basic and clinical research in endocrinology and metabolism. The objective of this call is to support young and promising researchers as well as established scientists, to carry out research projects of 1 to 3 years’ duration.

Closing date: 1 June 2017

Project grants within basic and clinical research in endocrinology and metabolism – NovoNordisk

Call ENDO project 2017 (pdf)

Postdoctoral fellowship program within endocrinology/metabolism at international elite research environments – NovoNordisk

With this call, the Novo Nordisk Foundation invites young, ambitious researchers in the Nordic countries to apply for a postdoctoral fellowship to conduct research within endocrinology and metabolism at elite institutions abroad. The fellowship offers an opportunity to carry out a research project where a minimum of 3 years are dedicated to work at a university, hospital or other research institution abroad, followed by up to 1 year at a university, hospital or other research institution in a Nordic county.

Closing date: 21 June 2017

Postdoctoral fellowship program within endocrinology/metabolism at international elite research environments – NovoNordisk

Call Postdoc abroad 2017 – ENDO (pdf)

Forskningsmedel - Stiftelsen Lantbruksforskning

Stiftelsen Lantbruksforskning utlyser härmed medel för forsknings- och utvecklingsprojekt inom stiftelsens fyra fokusområden; Livsmedel, Energi & biomassa, Klimat & miljö, Företagande. Stiftelsen beviljar medel till projekt som stärker lantbruksnäringens konkurrenskraft och hållbarhet.

Closing date: 1 June 2017

Forskningsmedel - Stiftelsen Lantbruksforskning

Post doc-stöd – AFA Försäkring

AFA Försäkring utlyser ett post doc-stöd på 2 miljoner kronor inom hälsoområdet. Syftet är att ge personer som är i början av sina forskarkarriärer ökade möjligheter till postdoktorala studier och forskning. AFA Försäkring vill främja den svenska kompetensutvecklingen inom området hälsa kopplat till arbetslivet och öka möjligheten till forskarkarriärer.

Closing date: 21 June 2017

Post doc-stöd – AFA Försäkring 

European grants

Partnering Grants - European food safety authority

Differently from other grant initiatives, Partnering Grants aim to promote capacity building at EU level through joint initiatives between two or preferably more organisations in different Member States, Norway and Iceland, enabling knowledge and expertise transfer and/or exchange within the fields of EFSA`s remit. For the purpose of this grant, Capacity Building is defined as an initiative that leads to the strengthening of food safety risk assessment capacity of national organisations through the transfer or exchange of knowledge, skills, competencies and abilities between partner organisations.

Closing date: 15 Sept 2017

Partnering Grants - European food safety authority

Annual research grant - European Society of Endodontology

This supports a pilot research project or the purchase of equipment for research in endodontology. The grant is worth up to €20,000 and may be split between several applicants.

Closing date: 1 Sep 2017 

Annual research grant - European Society of Endodontology

Research grants - European Leukodystrophy Association

These support innovative research in leukodystrophies. Grants are worth up to €100,000 over two years.

Closing date: 31 May 2017 

Research grants - European Leukodystrophy Association

Global exchange lecture courses - European Molecular Biology Organisation

The European Molecular Biology Organisation invites applications for its global exchange lecture courses. This supports the organisation of lecture courses in life sciences. Courses must take place in EMBO associate member states or cooperating partner countries. Meetings in Chile will be given preference. Applications should be made jointly by both a local and European scientist.

Closing date: 1 Aug 2017

Global exchange lecture courses - European Molecular Biology Organisation

Southeast Asia – Europe Joint Funding Scheme for Research and Innovation

SEA-EU-NET invites proposals for its Southeast Asia-Europe joint funding scheme for research and innovation. This aims to enhance bi-regional cooperation and develop new partnerships as well as strengthen existing ones through the following themes: health, including anti-microbial drug resistance and emerging infectious diseases; environment and climate change including adaptation and resilience of food production systems and impacts of climate change on ecosystems and biodiversity.

Closing date: 30 June 2017

National information

Southeast Asia – Europe Joint Funding Scheme for Research and Innovation

US and international grants

Integrative Computational Biology for Analysis of NHLBI TOPMed Data (R01)

The purpose of this Funding Opportunity Announcement (FOA) is to support integrated analysis of whole genome, large scale “omic” data generated by the NHLBI’s Trans-Omics for Precision Medicine (TOPMed) program and associated phenotype and clinical data using systems approaches. Ultimately, these studies will advance our understanding of the molecular underpinnings of heart, lung, blood, and sleep disease.

Closing dates: July 6, 2017 and July 6, 2018, by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-HL-18-020  

From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (R01) 

The primary objective of this FOA is to stimulate innovative Convergent Neuroscience (CN) approaches to establish causal and/or probabilistic linkages across contiguous levels of analysis (e.g., gene, molecule, cell, circuit, system, behavior) in an explanatory model of psychopathology. This FOA should be used when two or more collaborating sites are essential to complete the proposed research. It is required that the Research Strategy be identical across linked collaborative R01 applications, with the exception of a short section describing the specific function of each application under "elements unique to that site." Applications that stand alone and are not collaborative should come in under the companion R01 FOA (PAR-17-253).

Closing dates: Applications due by 5pm local time of applicant organisation every 5th February, 5th June and 5th October until 8th September 2020.

Funding Opportunity Announcement (FOA): PAR-17-252 & PAR-17-253  

Clinical Studies of Mental Illness Not Involving Clinical Trials (Collaborative R01)

This Funding Opportunity Announcement (FOA) seeks to support collaborative clinical studies, not involving treatment development, efficacy, or effectiveness trials. Primary areas of focus include mental health genetics, biomarker studies, and studies of mental illnesses (e.g., psychopathology, neurodevelopmental trajectories of psychopathology) also when associated with HIV/AIDS. Applicants should apply to this FOA when two or more sites are needed to complete the study.

Closing dates: Applications due by 5pm local time of applicant organisation every 5th February, 5th June and 5th October until 8th May 2020.

Funding Opportunity Announcement (FOA): PAR-17-256  

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)
This funding opportunity announcement (FOA) encourages applications that propose to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate the genetic architecture of cancer risk and related outcomes. The goal of this initiative is to address key scientific questions relevant to cancer epidemiology by supporting the analysis of existing genetic or genomic datasets, possibly in combination with environmental, outcomes, behavioral, lifestyle, and molecular profiles data.

Closing dates: Applications due by 5pm local time of applicant organisation every 5th February, 5th June and 5th October until 8th May 2020.

Funding Opportunity Announcement (FOA): PA-17-239  

Improving Health Care Capacity in Immuno-Oncology - Pfizer

The intent of this joint RFP is to offer organizations with a focus in health care professional education and/or quality improvement the opportunity to submit a Letter of Intent (LOI) in response to the RFP area of interest. This LOI can be related to education in a specific disease state and therapeutic area or a broader area of educational need and the system in which the education will be implemented.

Closing dates: May 1, 2017 (Letter of Intent), July 25, 2017 (Full Application), September 26, 2017 (Notification of Award).

Improving Health Care Capacity in Immuno-Oncology - Pfizer

Research Grant Program Request for Proposal - United Mitochondrial Disease Foundation (UMDF)

Within this resource are of interest to the Foundation. Example topics could include (but are not limited to):

• Serum or plasma-based biochemical signatures for the early diagnosis of mitochondrial disease, or the stratification of mitochondrial disease patients into specific disease sub-categories.

• Observational biomarkers for tracking progress of experimental therapies for mitochondrial disease during clinical trials.

• Behavioral biomarkers for monitoring disease progression (natural history) in patients diagnosed with mitochondrial disease.

• Novel genetic markers or other nucleic-acid based indicators of primary mitochondrial disease as a carrier or affected individual.

Closing date: April 24, 2017 (Full Application).

Research Grant Program Request for Proposal - United Mitochondrial Disease Foundation (UMDF)

Mathilde Krim Fellowships in Basic Biomedical Research (amfAR)

The goal of amfAR's Mathilde Krim Fellowships in Basic Biomedical Research is to: Facilitate the exceptional postdoctoral researcher's transition to an independent career in HIV/AIDS research within an academic institution or nonprofit organization; Support two years of postdoctoral basic biomedical research (phase I) and Provide the possibility of one additional year of research funding during the first year of an independent research position (phase II).

Closing dates: Request Instructions and Portal Log-in (REQUIRED) – 3:00 PM EDT, May 9, 2017
Letter of Intent Submission - 3:00 PM EDT, May 11, 2017

Mathilde Krim Fellowships in Basic Biomedical Research (amfAR) 

The 2017 DiaComp Pilot & Feasibility Program (NIDDK-sponsored Diabetic Complications Consortium (DiaComp)

This program aims to support discovery (hypothesis generating) and innovative (high risk/high reward) research that will advance our understanding of diabetic complications and is increasingly difficult to support through standard NIH mechanisms. Basic, translational and clinical research proposals are encouraged. Awards are expected to prepare the applicant(s) to submit a future investigator- initiated project (e.g. NIH R01). Applications of 5 pages are requested and up to $100,000 for one year.

Closing dates: June 12, 2017 (Submitted to DiaComp) and October 1st (Estimated Start Date), 2017.

The 2017 DiaComp Pilot & Feasibility Program (NIDDK-sponsored Diabetic Complications Consortium (DiaComp)

Grand Challenges Explorations (Bill & Gates Foundation)

Grand Challenges Explorations fosters early-stage discovery research to expand the pipeline of ideas for solving our greatest global health and development challenges. Launched in 2008 with an initial $100 million commitment from the foundation, Grand Challenges Explorations grants have already been awarded to more than 1200 researchers in more than 65 countries.

Initial grants will be US $100,000 each, and projects showing promise will have the opportunity to receive additional funding of up to US $1 million.

Closing date: May 3, 2017 (11:30am PDT).

Grand Challenges Explorations (Bill & Gates Foundation)  

Links

Grant